Industry Research Reports
Home > Reports > Chemical & Material > Global Urolithin A Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Urolithin A Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Chemical & Material
Published Date: 2025-08-05
Pages: 158 Pages
Report ld: 4855669
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Urolithin A Market Size(US$)
CAGR 2025-2031
6.1%
Market Size,2031
USD 59.3
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 41.6 million
Market Forecast in 2031(Value)
US$ 59.3 million
CAGR
6.1%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Urolithin A market is projected to grow from US$ 39.4 million in 2024 to US$ 59.3 million by 2031, at a CAGR of 6.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Urolithin A is a natural compound with multiple biological activities. It is a yellow or light yellow solid powder at room temperature and pressure. It can be dissolved in highly polar organic solvents such as dimethyl sulfoxide and N,N-dimethylformamide, but has poor solubility in low-polar petroleum ether and ether, and also has poor solubility in water.
Urolithin A is a secondary metabolite of the natural polyphenol compound ellagitannin metabolized by intestinal microorganisms, and is also an intestinal microbial metabolite of ellagic acid. After the human body ingests ellagitannin and ellagic acid, urolithin A is metabolized by intestinal flora.
Urolithin A can inhibit the activity of nuclear factor κB (NF-κB), reduce the production of inflammatory factors, and thus reduce inflammatory damage. As a mitochondrial autophagy inducer, urolithin A can prevent muscle aging and promote cell health, thereby playing an anti-aging role. It can also inhibit the activity of telomerase and delay cell aging. Urolithin A can scavenge free radicals in the body, protect cells from oxidative damage, and maintain the normal physiological functions of the body. It can also bind to peroxisome proliferator-activated receptor γ (PPARγ) and activate the PPARγ signaling pathway, thereby enhancing the antioxidant capacity of cells.
With the improvement of people's living standards and the enhancement of health awareness, the demand for natural compounds with health functions continues to increase. Urolithin A, as a natural compound with multiple biological activities such as anti-inflammatory, anti-aging, and antioxidant, meets this market demand.
In recent years, scientific research on urolithin A has continued to deepen, revealing more of its biological activities and health benefits. These research results provide a solid theoretical basis for the application of urolithin A and promote the development of its market.
The continuous advancement of preparation technology, especially the research and development and application of new preparation processes such as biofermentation, has improved the preparation efficiency and purity of urolithin A, reduced production costs, and provided technical support for its wide application.
Urolithin A has broad application prospects in many fields such as dietary supplements, cosmetics, medicines, and health products. This wide range of application areas provides broad space for the market development of urolithin A.
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Urolithin A market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Daicel
- Suzhou Myland Pharm & Nutrition Inc.
- Shenzhen Hygieia Biotech Co., Ltd
- Wuhan Senwayer Century Chemical Co.,Ltd
- Henan Chenli Biotechnology Co., LTD.
- Wuhan Hengheda Pharm Co., Ltd
- Shenyang Hongjiuzhou Chemical Co., Ltd.
- Shandong Airuike Chemical Co., Ltd.
- LEADER BIOCHEMICAL GROUP
- Cofttek
- Fengchen Group Co.,Ltd
- Natural Micron Chem Tech Co., Ltd.
- Dalian Handom Chemicals Co.,Ltd
- Shaanxi LonierHerb Bio-Technology Co., Ltd.
- Aktin Chemicals
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Purity: >98%
- Purity: >99%
- Others
Segment by Application
- Food Additives
- Cosmetics
- Drugs and Supplements
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Urolithin A study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Urolithin A: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Urolithin A Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Purity: >98%
1.2.3 Purity: >99%
1.2.4 Others
1.3 Market Segmentation by Application
1.3.1 Global Urolithin A Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Food Additives
1.3.3 Cosmetics
1.3.4 Drugs and Supplements
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Urolithin A Revenue Estimates and Forecasts 2020-2031
2.2 Global Urolithin A Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Urolithin A Sales Estimates and Forecasts 2020-2031
2.4 Global Urolithin A Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global Urolithin A Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 North America
3.4.2 Europe
3.4.3 China
3.4.4 Japan
4 Competition by Manufacturers
4.1 Global Urolithin A Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global Urolithin A Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 Purity: >98% Market Size by Manufacturers
4.5.2 Purity: >99% Market Size by Manufacturers
4.5.3 Others Market Size by Manufacturers
4.6 Global Urolithin A Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global Urolithin A Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global Urolithin A Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global Urolithin A Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global Urolithin A Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America Urolithin A Sales and Revenue by Type (2020-2031)
7.4 North America Urolithin A Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America Urolithin A Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe Urolithin A Sales and Revenue by Type (2020-2031)
8.4 Europe Urolithin A Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe Urolithin A Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific Urolithin A Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific Urolithin A Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific Urolithin A Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America Urolithin A Sales and Revenue by Type (2020-2031)
10.4 Central and South America Urolithin A Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America Urolithin A Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa Urolithin A Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa Urolithin A Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa Urolithin A Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 Daicel
12.1.1 Daicel Corporation Information
12.1.2 Daicel Business Overview
12.1.3 Daicel Urolithin A Product Models, Descriptions and Specifications
12.1.4 Daicel Urolithin A Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 Daicel Urolithin A Sales by Product in 2024
12.1.6 Daicel Urolithin A Sales by Application in 2024
12.1.7 Daicel Urolithin A Sales by Geographic Area in 2024
12.1.8 Daicel Urolithin A SWOT Analysis
12.1.9 Daicel Recent Developments
12.2 Suzhou Myland Pharm & Nutrition Inc.
12.2.1 Suzhou Myland Pharm & Nutrition Inc. Corporation Information
12.2.2 Suzhou Myland Pharm & Nutrition Inc. Business Overview
12.2.3 Suzhou Myland Pharm & Nutrition Inc. Urolithin A Product Models, Descriptions and Specifications
12.2.4 Suzhou Myland Pharm & Nutrition Inc. Urolithin A Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 Suzhou Myland Pharm & Nutrition Inc. Urolithin A Sales by Product in 2024
12.2.6 Suzhou Myland Pharm & Nutrition Inc. Urolithin A Sales by Application in 2024
12.2.7 Suzhou Myland Pharm & Nutrition Inc. Urolithin A Sales by Geographic Area in 2024
12.2.8 Suzhou Myland Pharm & Nutrition Inc. Urolithin A SWOT Analysis
12.2.9 Suzhou Myland Pharm & Nutrition Inc. Recent Developments
12.3 Shenzhen Hygieia Biotech Co., Ltd
12.3.1 Shenzhen Hygieia Biotech Co., Ltd Corporation Information
12.3.2 Shenzhen Hygieia Biotech Co., Ltd Business Overview
12.3.3 Shenzhen Hygieia Biotech Co., Ltd Urolithin A Product Models, Descriptions and Specifications
12.3.4 Shenzhen Hygieia Biotech Co., Ltd Urolithin A Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 Shenzhen Hygieia Biotech Co., Ltd Urolithin A Sales by Product in 2024
12.3.6 Shenzhen Hygieia Biotech Co., Ltd Urolithin A Sales by Application in 2024
12.3.7 Shenzhen Hygieia Biotech Co., Ltd Urolithin A Sales by Geographic Area in 2024
12.3.8 Shenzhen Hygieia Biotech Co., Ltd Urolithin A SWOT Analysis
12.3.9 Shenzhen Hygieia Biotech Co., Ltd Recent Developments
12.4 Wuhan Senwayer Century Chemical Co.,Ltd
12.4.1 Wuhan Senwayer Century Chemical Co.,Ltd Corporation Information
12.4.2 Wuhan Senwayer Century Chemical Co.,Ltd Business Overview
12.4.3 Wuhan Senwayer Century Chemical Co.,Ltd Urolithin A Product Models, Descriptions and Specifications
12.4.4 Wuhan Senwayer Century Chemical Co.,Ltd Urolithin A Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 Wuhan Senwayer Century Chemical Co.,Ltd Urolithin A Sales by Product in 2024
12.4.6 Wuhan Senwayer Century Chemical Co.,Ltd Urolithin A Sales by Application in 2024
12.4.7 Wuhan Senwayer Century Chemical Co.,Ltd Urolithin A Sales by Geographic Area in 2024
12.4.8 Wuhan Senwayer Century Chemical Co.,Ltd Urolithin A SWOT Analysis
12.4.9 Wuhan Senwayer Century Chemical Co.,Ltd Recent Developments
12.5 Henan Chenli Biotechnology Co., LTD.
12.5.1 Henan Chenli Biotechnology Co., LTD. Corporation Information
12.5.2 Henan Chenli Biotechnology Co., LTD. Business Overview
12.5.3 Henan Chenli Biotechnology Co., LTD. Urolithin A Product Models, Descriptions and Specifications
12.5.4 Henan Chenli Biotechnology Co., LTD. Urolithin A Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.5 Henan Chenli Biotechnology Co., LTD. Urolithin A Sales by Product in 2024
12.5.6 Henan Chenli Biotechnology Co., LTD. Urolithin A Sales by Application in 2024
12.5.7 Henan Chenli Biotechnology Co., LTD. Urolithin A Sales by Geographic Area in 2024
12.5.8 Henan Chenli Biotechnology Co., LTD. Urolithin A SWOT Analysis
12.5.9 Henan Chenli Biotechnology Co., LTD. Recent Developments
12.6 Wuhan Hengheda Pharm Co., Ltd
12.6.1 Wuhan Hengheda Pharm Co., Ltd Corporation Information
12.6.2 Wuhan Hengheda Pharm Co., Ltd Business Overview
12.6.3 Wuhan Hengheda Pharm Co., Ltd Urolithin A Product Models, Descriptions and Specifications
12.6.4 Wuhan Hengheda Pharm Co., Ltd Urolithin A Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.6.5 Wuhan Hengheda Pharm Co., Ltd Recent Developments
12.7 Shenyang Hongjiuzhou Chemical Co., Ltd.
12.7.1 Shenyang Hongjiuzhou Chemical Co., Ltd. Corporation Information
12.7.2 Shenyang Hongjiuzhou Chemical Co., Ltd. Business Overview
12.7.3 Shenyang Hongjiuzhou Chemical Co., Ltd. Urolithin A Product Models, Descriptions and Specifications
12.7.4 Shenyang Hongjiuzhou Chemical Co., Ltd. Urolithin A Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.7.5 Shenyang Hongjiuzhou Chemical Co., Ltd. Recent Developments
12.8 Shandong Airuike Chemical Co., Ltd.
12.8.1 Shandong Airuike Chemical Co., Ltd. Corporation Information
12.8.2 Shandong Airuike Chemical Co., Ltd. Business Overview
12.8.3 Shandong Airuike Chemical Co., Ltd. Urolithin A Product Models, Descriptions and Specifications
12.8.4 Shandong Airuike Chemical Co., Ltd. Urolithin A Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.8.5 Shandong Airuike Chemical Co., Ltd. Recent Developments
12.9 LEADER BIOCHEMICAL GROUP
12.9.1 LEADER BIOCHEMICAL GROUP Corporation Information
12.9.2 LEADER BIOCHEMICAL GROUP Business Overview
12.9.3 LEADER BIOCHEMICAL GROUP Urolithin A Product Models, Descriptions and Specifications
12.9.4 LEADER BIOCHEMICAL GROUP Urolithin A Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.9.5 LEADER BIOCHEMICAL GROUP Recent Developments
12.10 Cofttek
12.10.1 Cofttek Corporation Information
12.10.2 Cofttek Business Overview
12.10.3 Cofttek Urolithin A Product Models, Descriptions and Specifications
12.10.4 Cofttek Urolithin A Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.10.5 Cofttek Recent Developments
12.11 Fengchen Group Co.,Ltd
12.11.1 Fengchen Group Co.,Ltd Corporation Information
12.11.2 Fengchen Group Co.,Ltd Business Overview
12.11.3 Fengchen Group Co.,Ltd Urolithin A Product Models, Descriptions and Specifications
12.11.4 Fengchen Group Co.,Ltd Urolithin A Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.11.5 Fengchen Group Co.,Ltd Recent Developments
12.12 Natural Micron Chem Tech Co., Ltd.
12.12.1 Natural Micron Chem Tech Co., Ltd. Corporation Information
12.12.2 Natural Micron Chem Tech Co., Ltd. Business Overview
12.12.3 Natural Micron Chem Tech Co., Ltd. Urolithin A Product Models, Descriptions and Specifications
12.12.4 Natural Micron Chem Tech Co., Ltd. Urolithin A Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.12.5 Natural Micron Chem Tech Co., Ltd. Recent Developments
12.13 Dalian Handom Chemicals Co.,Ltd
12.13.1 Dalian Handom Chemicals Co.,Ltd Corporation Information
12.13.2 Dalian Handom Chemicals Co.,Ltd Business Overview
12.13.3 Dalian Handom Chemicals Co.,Ltd Urolithin A Product Models, Descriptions and Specifications
12.13.4 Dalian Handom Chemicals Co.,Ltd Urolithin A Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.13.5 Dalian Handom Chemicals Co.,Ltd Recent Developments
12.14 Shaanxi LonierHerb Bio-Technology Co., Ltd.
12.14.1 Shaanxi LonierHerb Bio-Technology Co., Ltd. Corporation Information
12.14.2 Shaanxi LonierHerb Bio-Technology Co., Ltd. Business Overview
12.14.3 Shaanxi LonierHerb Bio-Technology Co., Ltd. Urolithin A Product Models, Descriptions and Specifications
12.14.4 Shaanxi LonierHerb Bio-Technology Co., Ltd. Urolithin A Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.14.5 Shaanxi LonierHerb Bio-Technology Co., Ltd. Recent Developments
12.15 Aktin Chemicals
12.15.1 Aktin Chemicals Corporation Information
12.15.2 Aktin Chemicals Business Overview
12.15.3 Aktin Chemicals Urolithin A Product Models, Descriptions and Specifications
12.15.4 Aktin Chemicals Urolithin A Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.15.5 Aktin Chemicals Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 Urolithin A Industry Chain
13.2 Urolithin A Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 Urolithin A Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 Urolithin A Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 Urolithin A Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global Urolithin A Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Urolithin A Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Urolithin A Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Urolithin A Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Urolithin A Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Urolithin A Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Urolithin A Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
Table 7. Global Urolithin A Sales by Region (2020-2025) & (Tons)
Table 8. Global Urolithin A Sales by Region (2026-2031) & (Tons)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Urolithin A Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
Table 11. Global Urolithin A Production by Region (2020-2025) & (Tons)
Table 12. Global Urolithin A Production by Region (2026-2031) & (Tons)
Table 13. Global Urolithin A Sales by Manufacturers (2020-2025) & (Tons)
Table 14. Global Urolithin A Sales Share by Manufacturers (2020-2025)
Table 15. Global Urolithin A Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 16. Global Urolithin A Revenue Market Share by Manufacturers (2020-2025)
Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 18. Global Urolithin A by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Urolithin A as of 2024)
Table 19. Global Urolithin A Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 20. Global Urolithin A Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Ton)
Table 21. Key Manufacturers Urolithin A Manufacturing Base and Headquarters
Table 22. Global Urolithin A Market Concentration Ratio (CR5 and HHI)
Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 25. Global Urolithin A Sales by Type (2020-2025) & (Tons)
Table 26. Global Urolithin A Sales by Type (2026-2031) & (Tons)
Table 27. Global Urolithin A Revenue by Type (2020-2025) & (US$ Million)
Table 28. Global Urolithin A Revenue by Type (2026-2031) & (US$ Million)
Table 29. Global Urolithin A ASP by Type (2020-2031) & (US$/Ton)
Table 30. Technical Specifications by Key Product Type
Table 31. Global Urolithin A Sales by Application (2020-2025) & (Tons)
Table 32. Global Urolithin A Sales by Application (2026-2031) & (Tons)
Table 33. Urolithin A High-Growth Sectors Demand CAGR (2024-2031)
Table 34. Global Urolithin A Revenue by Application (2020-2025) & (US$ Million)
Table 35. Global Urolithin A Revenue by Application (2026-2031) & (US$ Million)
Table 36. Global Urolithin A ASP by Application (2020-2031) & (US$/Ton)
Table 37. Top Customers by Region
Table 38. Top Customers by Application
Table 39. North America Urolithin A Growth Accelerators and Market Barriers
Table 40. North America Urolithin A Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 41. North America Urolithin A Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 42. Europe Urolithin A Growth Accelerators and Market Barriers
Table 43. Europe Urolithin A Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 44. Europe Urolithin A Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 45. Asia-Pacific Urolithin A Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Asia-Pacific Urolithin A Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 47. Asia-Pacific Urolithin A Growth Accelerators and Market Barriers
Table 48. Southeast Asia Urolithin A Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 49. Central and South America Urolithin A Investment Opportunities and Key Challenges
Table 50. Central and South America Urolithin A Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 51. Middle East and Africa Urolithin A Investment Opportunities and Key Challenges
Table 52. Middle East and Africa Urolithin A Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 53. Daicel Corporation Information
Table 54. Daicel Description and Major Businesses
Table 55. Daicel Product Models, Descriptions and Specifications
Table 56. Daicel Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 57. Daicel Sales Value Proportion by Product in 2024
Table 58. Daicel Sales Value Proportion by Application in 2024
Table 59. Daicel Sales Value Proportion by Geographic Area in 2024
Table 60. Daicel Urolithin A SWOT Analysis
Table 61. Daicel Recent Developments
Table 62. Suzhou Myland Pharm & Nutrition Inc. Corporation Information
Table 63. Suzhou Myland Pharm & Nutrition Inc. Description and Major Businesses
Table 64. Suzhou Myland Pharm & Nutrition Inc. Product Models, Descriptions and Specifications
Table 65. Suzhou Myland Pharm & Nutrition Inc. Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 66. Suzhou Myland Pharm & Nutrition Inc. Sales Value Proportion by Product in 2024
Table 67. Suzhou Myland Pharm & Nutrition Inc. Sales Value Proportion by Application in 2024
Table 68. Suzhou Myland Pharm & Nutrition Inc. Sales Value Proportion by Geographic Area in 2024
Table 69. Suzhou Myland Pharm & Nutrition Inc. Urolithin A SWOT Analysis
Table 70. Suzhou Myland Pharm & Nutrition Inc. Recent Developments
Table 71. Shenzhen Hygieia Biotech Co., Ltd Corporation Information
Table 72. Shenzhen Hygieia Biotech Co., Ltd Description and Major Businesses
Table 73. Shenzhen Hygieia Biotech Co., Ltd Product Models, Descriptions and Specifications
Table 74. Shenzhen Hygieia Biotech Co., Ltd Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 75. Shenzhen Hygieia Biotech Co., Ltd Sales Value Proportion by Product in 2024
Table 76. Shenzhen Hygieia Biotech Co., Ltd Sales Value Proportion by Application in 2024
Table 77. Shenzhen Hygieia Biotech Co., Ltd Sales Value Proportion by Geographic Area in 2024
Table 78. Shenzhen Hygieia Biotech Co., Ltd Urolithin A SWOT Analysis
Table 79. Shenzhen Hygieia Biotech Co., Ltd Recent Developments
Table 80. Wuhan Senwayer Century Chemical Co.,Ltd Corporation Information
Table 81. Wuhan Senwayer Century Chemical Co.,Ltd Description and Major Businesses
Table 82. Wuhan Senwayer Century Chemical Co.,Ltd Product Models, Descriptions and Specifications
Table 83. Wuhan Senwayer Century Chemical Co.,Ltd Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 84. Wuhan Senwayer Century Chemical Co.,Ltd Sales Value Proportion by Product in 2024
Table 85. Wuhan Senwayer Century Chemical Co.,Ltd Sales Value Proportion by Application in 2024
Table 86. Wuhan Senwayer Century Chemical Co.,Ltd Sales Value Proportion by Geographic Area in 2024
Table 87. Wuhan Senwayer Century Chemical Co.,Ltd Urolithin A SWOT Analysis
Table 88. Wuhan Senwayer Century Chemical Co.,Ltd Recent Developments
Table 89. Henan Chenli Biotechnology Co., LTD. Corporation Information
Table 90. Henan Chenli Biotechnology Co., LTD. Description and Major Businesses
Table 91. Henan Chenli Biotechnology Co., LTD. Product Models, Descriptions and Specifications
Table 92. Henan Chenli Biotechnology Co., LTD. Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 93. Henan Chenli Biotechnology Co., LTD. Sales Value Proportion by Product in 2024
Table 94. Henan Chenli Biotechnology Co., LTD. Sales Value Proportion by Application in 2024
Table 95. Henan Chenli Biotechnology Co., LTD. Sales Value Proportion by Geographic Area in 2024
Table 96. Henan Chenli Biotechnology Co., LTD. Urolithin A SWOT Analysis
Table 97. Henan Chenli Biotechnology Co., LTD. Recent Developments
Table 98. Wuhan Hengheda Pharm Co., Ltd Corporation Information
Table 99. Wuhan Hengheda Pharm Co., Ltd Description and Major Businesses
Table 100. Wuhan Hengheda Pharm Co., Ltd Product Models, Descriptions and Specifications
Table 101. Wuhan Hengheda Pharm Co., Ltd Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 102. Wuhan Hengheda Pharm Co., Ltd Recent Developments
Table 103. Shenyang Hongjiuzhou Chemical Co., Ltd. Corporation Information
Table 104. Shenyang Hongjiuzhou Chemical Co., Ltd. Description and Major Businesses
Table 105. Shenyang Hongjiuzhou Chemical Co., Ltd. Product Models, Descriptions and Specifications
Table 106. Shenyang Hongjiuzhou Chemical Co., Ltd. Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 107. Shenyang Hongjiuzhou Chemical Co., Ltd. Recent Developments
Table 108. Shandong Airuike Chemical Co., Ltd. Corporation Information
Table 109. Shandong Airuike Chemical Co., Ltd. Description and Major Businesses
Table 110. Shandong Airuike Chemical Co., Ltd. Product Models, Descriptions and Specifications
Table 111. Shandong Airuike Chemical Co., Ltd. Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 112. Shandong Airuike Chemical Co., Ltd. Recent Developments
Table 113. LEADER BIOCHEMICAL GROUP Corporation Information
Table 114. LEADER BIOCHEMICAL GROUP Description and Major Businesses
Table 115. LEADER BIOCHEMICAL GROUP Product Models, Descriptions and Specifications
Table 116. LEADER BIOCHEMICAL GROUP Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 117. LEADER BIOCHEMICAL GROUP Recent Developments
Table 118. Cofttek Corporation Information
Table 119. Cofttek Description and Major Businesses
Table 120. Cofttek Product Models, Descriptions and Specifications
Table 121. Cofttek Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 122. Cofttek Recent Developments
Table 123. Fengchen Group Co.,Ltd Corporation Information
Table 124. Fengchen Group Co.,Ltd Description and Major Businesses
Table 125. Fengchen Group Co.,Ltd Product Models, Descriptions and Specifications
Table 126. Fengchen Group Co.,Ltd Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 127. Fengchen Group Co.,Ltd Recent Developments
Table 128. Natural Micron Chem Tech Co., Ltd. Corporation Information
Table 129. Natural Micron Chem Tech Co., Ltd. Description and Major Businesses
Table 130. Natural Micron Chem Tech Co., Ltd. Product Models, Descriptions and Specifications
Table 131. Natural Micron Chem Tech Co., Ltd. Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 132. Natural Micron Chem Tech Co., Ltd. Recent Developments
Table 133. Dalian Handom Chemicals Co.,Ltd Corporation Information
Table 134. Dalian Handom Chemicals Co.,Ltd Description and Major Businesses
Table 135. Dalian Handom Chemicals Co.,Ltd Product Models, Descriptions and Specifications
Table 136. Dalian Handom Chemicals Co.,Ltd Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 137. Dalian Handom Chemicals Co.,Ltd Recent Developments
Table 138. Shaanxi LonierHerb Bio-Technology Co., Ltd. Corporation Information
Table 139. Shaanxi LonierHerb Bio-Technology Co., Ltd. Description and Major Businesses
Table 140. Shaanxi LonierHerb Bio-Technology Co., Ltd. Product Models, Descriptions and Specifications
Table 141. Shaanxi LonierHerb Bio-Technology Co., Ltd. Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 142. Shaanxi LonierHerb Bio-Technology Co., Ltd. Recent Developments
Table 143. Aktin Chemicals Corporation Information
Table 144. Aktin Chemicals Description and Major Businesses
Table 145. Aktin Chemicals Product Models, Descriptions and Specifications
Table 146. Aktin Chemicals Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 147. Aktin Chemicals Recent Developments
Table 148. Key Raw Materials Distribution
Table 149. Raw Materials Key Suppliers
Table 150. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 151. Milestones in Production Technology Evolution
Table 152. Distributors List
Table 153. Market Trends and Market Evolution
Table 154. Market Drivers and Opportunities
Table 155. Market Challenges, Risks, and Restraints
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
List of Figures
Figure 1. Urolithin A Product Picture
Figure 2. Global Urolithin A Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Purity: >98% Product Picture
Figure 4. Purity: >99% Product Picture
Figure 5. Others Product Picture
Figure 6. Global Urolithin A Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Food Additives
Figure 8. Cosmetics
Figure 9. Drugs and Supplements
Figure 10. Others
Figure 11. Urolithin A Report Years Considered
Figure 12. Global Urolithin A Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Urolithin A Revenue (2020-2031) & (US$ Million)
Figure 14. Global Urolithin A Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 15. Global Urolithin A Revenue Market Share by Region (2020-2031)
Figure 16. Global Urolithin A Sales (2020-2031) & (Tons)
Figure 17. Global Urolithin A Sales (CAGR) by Region (2020-2031) (Tons)
Figure 18. Global Urolithin A Sales Market Share by Region (2020-2031)
Figure 19. Global Urolithin A Capacity, Production and Utilization (2020-2031) & (Tons)
Figure 20. Global Urolithin A Production Trend by Region (2020-2031) (Tons)
Figure 21. Global Urolithin A Production Market Share by Region (2020-2031)
Figure 22. Production Capacity Enablers & Constraints
Figure 23. Urolithin A Production Growth Rate in North America (2020-2031) & (Tons)
Figure 24. Urolithin A Production Growth Rate in Europe (2020-2031) & (Tons)
Figure 25. Urolithin A Production Growth Rate in China (2020-2031) & (Tons)
Figure 26. Urolithin A Production Growth Rate in Japan (2020-2031) & (Tons)
Figure 27. Top 5 and Top 10 Manufacturers Urolithin A Sales Volume Market Share in 2024
Figure 28. Global Urolithin A Revenue Market Share Ranking (2024)
Figure 29. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 30. Purity: >98% Revenue Market Share by Manufacturer in 2024
Figure 31. Purity: >99% Revenue Market Share by Manufacturer in 2024
Figure 32. Others Revenue Market Share by Manufacturer in 2024
Figure 33. Type Eight Revenue Market Share by Manufacturer in 2024
Figure 34. Type Nine Revenue Market Share by Manufacturer in 2024
Figure 35. Global Urolithin A Sales Market Share by Type (2020-2031)
Figure 36. Global Urolithin A Revenue Market Share by Type (2020-2031)
Figure 37. Global Urolithin A Sales Market Share by Application (2020-2031)
Figure 38. Global Urolithin A Revenue Market Share by Application (2020-2031)
Figure 39. North America Urolithin A Sales YoY (2020-2031) & (Tons)
Figure 40. North America Urolithin A Revenue YoY (2020-2031) & (US$ Million)
Figure 41. North America Top 5 Manufacturers Urolithin A Sales Revenue (US$ Million) in 2024
Figure 42. North America Urolithin A Sales Volume (Tons) by Type (2020- 2031)
Figure 43. North America Urolithin A Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 44. North America Urolithin A Sales Volume (Tons) by Application (2020-2031)
Figure 45. North America Urolithin A Sales Revenue (US$ Million) by Application (2020-2031)
Figure 46. US Urolithin A Revenue (2020-2031) & (US$ Million)
Figure 47. Canada Urolithin A Revenue (2020-2031) & (US$ Million)
Figure 48. Mexico Urolithin A Revenue (2020-2031) & (US$ Million)
Figure 49. Europe Urolithin A Sales YoY (2020-2031) & (Tons)
Figure 50. Europe Urolithin A Revenue YoY (2020-2031) & (US$ Million)
Figure 51. Europe Top 5 Manufacturers Urolithin A Sales Revenue (US$ Million) in 2024
Figure 52. Europe Urolithin A Sales Volume (Tons) by Type (2020-2031)
Figure 53. Europe Urolithin A Sales Revenue (US$ Million) by Type (2020-2031)
Figure 54. Europe Urolithin A Sales Volume (Tons) by Application (2020-2031)
Figure 55. Europe Urolithin A Sales Revenue (US$ Million) by Application (2020-2031)
Figure 56. Germany Urolithin A Revenue (2020-2031) & (US$ Million)
Figure 57. France Urolithin A Revenue (2020-2031) & (US$ Million)
Figure 58. U.K. Urolithin A Revenue (2020-2031) & (US$ Million)
Figure 59. Italy Urolithin A Revenue (2020-2031) & (US$ Million)
Figure 60. Russia Urolithin A Revenue (2020-2031) & (US$ Million)
Figure 61. Asia-Pacific Urolithin A Sales YoY (2020-2031) & (Tons)
Figure 62. Asia-Pacific Urolithin A Revenue YoY (2020-2031) & (US$ Million)
Figure 63. Asia-Pacific Top 8 Manufacturers Urolithin A Sales Revenue (US$ Million) in 2024
Figure 64. Asia-Pacific Urolithin A Sales Volume (Tons) by Type (2020- 2031)
Figure 65. Asia-Pacific Urolithin A Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 66. Asia-Pacific Urolithin A Sales Volume (Tons) by Application (2020-2031)
Figure 67. Asia-Pacific Urolithin A Sales Revenue (US$ Million) by Application (2020-2031)
Figure 68. Indonesia Urolithin A Revenue (2020-2031) & (US$ Million)
Figure 69. Japan Urolithin A Revenue (2020-2031) & (US$ Million)
Figure 70. South Korea Urolithin A Revenue (2020-2031) & (US$ Million)
Figure 71. China Taiwan Urolithin A Revenue (2020-2031) & (US$ Million)
Figure 72. India Urolithin A Revenue (2020-2031) & (US$ Million)
Figure 73. Central and South America Urolithin A Sales YoY (2020-2031) & (Tons)
Figure 74. Central and South America Urolithin A Revenue YoY (2020-2031) & (US$ Million)
Figure 75. Central and South America Top 5 Manufacturers Urolithin A Sales Revenue (US$ Million) in 2024
Figure 76. Central and South America Urolithin A Sales Volume (Tons) by Type (2021-2031)
Figure 77. Central and South America Urolithin A Sales Revenue (US$ Million) by Type (2020-2031)
Figure 78. Central and South America Urolithin A Sales Volume (Tons) by Application (2020-2031)
Figure 79. Central and South America Urolithin A Sales Revenue (US$ Million) by Application (2020-2031)
Figure 80. Brazil Urolithin A Revenue (2020-2025) & (US$ Million)
Figure 81. Argentina Urolithin A Revenue (2020-2025) & (US$ Million)
Figure 82. Middle East, and Africa Urolithin A Sales YoY (2020-2031) & (Tons)
Figure 83. Middle East and Africa Urolithin A Revenue YoY (2020-2031) & (US$ Million)
Figure 84. Middle East and Africa Top 5 Manufacturers Urolithin A Sales Revenue (US$ Million) in 2024
Figure 85. Middle East and Africa Urolithin A Sales Volume (Tons) by Type (2021-2031)
Figure 86. South America Urolithin A Sales Revenue (US$ Million) by Type (2020-2031)
Figure 87. Middle East and Africa Urolithin A Sales Volume (Tons) by Application (2020-2031)
Figure 88. Middle East and Africa Urolithin A Sales Revenue (US$ Million) by Application (2020-2031)
Figure 89. GCC Countries Urolithin A Revenue (2020-2025) & (US$ Million)
Figure 90. Turkey Urolithin A Revenue (2020-2025) & (US$ Million)
Figure 91. Egypt Urolithin A Revenue (2020-2025) & (US$ Million)
Figure 92. South Africa Urolithin A Revenue (2020-2025) & (US$ Million)
Figure 93. Urolithin A Industry Chain Mapping
Figure 94. Regional Urolithin A Manufacturing Base Distribution (%)
Figure 95. Urolithin A Production Process
Figure 96. Regional Urolithin A Production Cost Structure
Figure 97. Channels of Distribution (Direct Vs Distribution)
Figure 98. Bottom-up and Top-down Approaches for This Report
Figure 99. Data Triangulation
Figure 100. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Urolithin A market?
The top companies in the global Urolithin A market are Daicel、Suzhou Myland Pharm & Nutrition Inc.、Shenzhen Hygieia Biotech Co., Ltd.
Which region is expected to have the highest market share?
What is the annual compound growth rate of the global Urolithin A market size from 2025 to 2031?
What was the global market size of Urolithin A in 2031?
What was the global market size of Urolithin A in 2025?
Related Reports
Global Urolithin A Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Urolithin A market is projected to grow from US$ 41.56 million in 2025 to US$ 62.54 million by 2032, at a CAGR of 6.1% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 160
USD 4900.00
(Single User License)
Global Urolithin A Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Urolithin A market size was US$ 41.56 million in 2025 and is forecast to reach a readjusted size of US$ 62.54 million by 2032 with a CAGR of 6.1% during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 97
USD 4250.00
(Single User License)
Urolithin A- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Urolithin A was estimated to be worth US$ 41.56 million in 2025 and is projected to reach US$ 62.54 million, growing at a CAGR of 6.1% from 2026 to 2032.
Published Date: 2026-01-09
Pages: 111
USD 3950.00
(Single User License)
Global Urolithin A Market Research Report 2026
The global Urolithin A market was valued at US$ 41.56 million in 2025 and is anticipated to reach US$ 62.54 million by 2032, at a CAGR of 6.1% from 2026 to 2032.
Published Date: 2026-01-09
Pages: 144
USD 2900.00
(Single User License)
Global Urolithin A Market Research Report 2025
The global market for Urolithin A was valued at US$ 39.4 million in the year 2024 and is projected to reach a revised size of US$ 59.3 million by 2031, growing at a CAGR of 6.1% during the forecast period.
Published Date: 2025-03-10
Pages: 100
USD 2900.00
(Single User License)
Global Urolithin A Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Urolithin A market size was US$ 39.4 million in 2024 and is forecast to a readjusted size of US$ 59.3 million by 2031 with a CAGR of 6.1% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 91
USD 4250.00
(Single User License)
Urolithin A - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Urolithin A was estimated to be worth US$ 39.4 million in 2024 and is forecast to a readjusted size of US$ 59.3 million by 2031 with a CAGR of 6.1% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 115
USD 3950.00
(Single User License)
Global Urolithin A Market Insights, Forecast to 2031
Valued at US$ 41.6 million in 2024, the global Urolithin A market is forecast to reach US$ 59.3 million by 2030, at a CAGR of 6.1% during the forecast period.
Published Date: 2025-03-03
Pages: 151
USD 4900.00
(Single User License)
Global Urolithin A Market Research Report 2024
Urolithin A is a gut microbiome-derived metabolite obtained through the fermentation of pomegranate polyphenols such as ellagic acid and ellagitannins. It is a compound that promotes mitochondrial health and ATP production for healthier ageing and longevity.
Published Date: 2024-09-11
Pages: 97
USD 2900.00
(Single User License)
Global and United States Urolithin A Market Report & Forecast 2024-2030
Urolithin A is a gut microbiome-derived metabolite obtained through the fermentation of pomegranate polyphenols such as ellagic acid and ellagitannins. It is a compound that promotes mitochondrial health and ATP production for healthier ageing and longevity.
Published Date: 2024-09-11
Pages: 124
USD 4350.00
(Single User License)
Global Urolithin A Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Urolithin A market is projected to grow from US$ 41.56 million in 2025 to US$ 62.54 million by 2032, at a CAGR of 6.1% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 160
USD 4900.00 (Single User License)Global Urolithin A Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Urolithin A market size was US$ 41.56 million in 2025 and is forecast to reach a readjusted size of US$ 62.54 million by 2032 with a CAGR of 6.1% during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 97
USD 4250.00 (Single User License)Urolithin A- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Urolithin A was estimated to be worth US$ 41.56 million in 2025 and is projected to reach US$ 62.54 million, growing at a CAGR of 6.1% from 2026 to 2032.
Published: 2026-01-09
Pages: 111
USD 3950.00 (Single User License)Global Urolithin A Market Research Report 2026
The global Urolithin A market was valued at US$ 41.56 million in 2025 and is anticipated to reach US$ 62.54 million by 2032, at a CAGR of 6.1% from 2026 to 2032.
Published: 2026-01-09
Pages: 144
USD 2900.00 (Single User License)Global Urolithin A Market Research Report 2025
The global market for Urolithin A was valued at US$ 39.4 million in the year 2024 and is projected to reach a revised size of US$ 59.3 million by 2031, growing at a CAGR of 6.1% during the forecast period.
Published: 2025-03-10
Pages: 100
USD 2900.00 (Single User License)Global Urolithin A Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Urolithin A market size was US$ 39.4 million in 2024 and is forecast to a readjusted size of US$ 59.3 million by 2031 with a CAGR of 6.1% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 91
USD 4250.00 (Single User License)Urolithin A - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Urolithin A was estimated to be worth US$ 39.4 million in 2024 and is forecast to a readjusted size of US$ 59.3 million by 2031 with a CAGR of 6.1% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 115
USD 3950.00 (Single User License)Global Urolithin A Market Insights, Forecast to 2031
Valued at US$ 41.6 million in 2024, the global Urolithin A market is forecast to reach US$ 59.3 million by 2030, at a CAGR of 6.1% during the forecast period.
Published: 2025-03-03
Pages: 151
USD 4900.00 (Single User License)Global Urolithin A Market Research Report 2024
Urolithin A is a gut microbiome-derived metabolite obtained through the fermentation of pomegranate polyphenols such as ellagic acid and ellagitannins. It is a compound that promotes mitochondrial health and ATP production for healthier ageing and longevity.
Published: 2024-09-11
Pages: 97
USD 2900.00 (Single User License)Global and United States Urolithin A Market Report & Forecast 2024-2030
Urolithin A is a gut microbiome-derived metabolite obtained through the fermentation of pomegranate polyphenols such as ellagic acid and ellagitannins. It is a compound that promotes mitochondrial health and ATP production for healthier ageing and longevity.
Published: 2024-09-11
Pages: 124
USD 4350.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now